Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Pharmacognosy MagazineNOW IN
    Article

    Pila globosa Snail Extract Inhibits Osteoclast Differentiation via Downregulation of Nuclear Factor κB and Nuclear Factor of

    Activated T‑Cells c1 Signaling Pathways Shanmuganathan Pandiarajan1, Shila Samuel2★, Tholcopiyan Loganathan2, Shyam Sundar Jaganathan2, Thiagarajan Krishnamurthi2, Radhakrishnan Sarangapani2, Vinod Kumar Anandan2, Ramasubramanian Venkatachalam1★★ Corresponding author

    1. 1Department of Zoology, Unit of Aquatic Biotechnology and Live Feed Culture, School of Life Sciences, Bharathiar University, Coimbatore, India.
    2. 2Department of Biochemistry, VRR Institute of Biomedical Science (Affiliated to University of Madras), Chennai, Tamil Nadu, India.

    CORRESPONDENCE

    Shila Samuel

    Department of Biochemistry, VRR Institute of Biomedical Science (Affiliated to University of Madras), Chennai, Tamil Nadu, India.

    shilasamuel72@gmail.com

    Received: 31-01-2019; Revised: 21-03-2019.

    Volume 15, Issue 64s · pp. S298–S306 · PUBLISHED 26 August 2019 · DOI: 10.4103/pm.pm_39_19

    View on Pharmacogn. Mag. original site ↗

    ABSTRACT

    Objective: The current study describes for the first time that Pila globosa snail extract inhibits osteoclastogenesis in vitro and thus suppresses bone loss in ovariectomy‑induced rat model. Materials and Methods: Ovariectomized (Ovx) rats were treated with P. globosa snail extract and compared with sham, Ovx, and Ovx treated with zoledronate groups. Serum levels of C‑terminal crosslinking telopeptides of type‑1 collagen (CTX‑1), TRAP5b, and antioxidant markers were determined. mRNA expressions of cathepsin K (CTSK), TRAP, calcitonin receptor (CTR), and matrix metalloproteinase 9 (MMP‑9) were also assessed. Immunoblots of nuclear factor of activated T‑cells c1 (NFATc1), c‑Fos, TNF receptor‑associated factor 6, c‑Jun, and nuclear factor κB (NFκB) proteins were analyzed. Results and Discussion: P. globosa snail extract induced a decrease in the activation of NFκB, c‑Fos, and NFATc1, which resulted in the downregulation of target genes, CTSK, TRAP, CTR, and MMP‑9. P. globosa snail extract decreased the serum markers of bone resorption, C-terminal telopeptides of type-1 collagen (CTX‑1), and tartrate-resistant acid phosphatase 5b (TRAP5b), reflecting the reduced number and activity of osteoclasts. Moreover, the results also suggested that the protective effect of P. globosa snail extract against osteoporosis is associated with the reduction of oxidative stress as evidenced by decreased malondialdehyde and increased serum antioxidant markers, superoxide dismutase, catalase, and glutathione. Conclusion: The upshot of the study suggests that the P. globosa snail extract represents a potential treatment option against osteolytic bone disease.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Pandiarajan, A. T. C. S. P. S., Samuel, S., Loganathan, T., Jaganathan, S. S., Krishnamurthi, T., Sarangapani, R., Anandan, V. K., & Venkatachalam, R. (2019). Pila globosa Snail Extract Inhibits Osteoclast Differentiation via Downregulation of Nuclear Factor κB and Nuclear Factor of. Pharmacognosy Magazine, 15(64s), S298–S306. https://doi.org/10.4103/pm.pm_39_19